查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606719

数位 PCR 和即时PCR市场：按类型、产品类型、应用和最终用户 - 2025-2030 年全球预测

Digital PCR & Real-Time PCR Market by Type (dPCR, qPCR), Product Type (Instruments, Reagents & Consumables, Services), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年数位PCR和即时PCR市场价值为82.4亿美元，预计到2024年将达到88.7亿美元，复合年增长率为7.98%，到2030年将达到141.1亿美元。

数位 PCR (dPCR) 和即时PCR(qPCR) 市场重点关注用于准确定量 DNA 和 RNA 扩增的分子生物学技术。两者在诊断、研究和应用科学中都发挥着重要作用。遗传疾病检测、癌症研究、病原体检测（包括COVID-19）和基因分型等领域的应用凸显了对这些技术的需求，并广泛应用于医院、诊断中心、研究机构等。各领域用户。主要成长动力包括生物技术的进步、感染疾病的传播、个人化医疗需求的增加以及基因组研究资金的增加。机会在于提高灵敏度和准确性、自动化以及人工智慧对资料解释的集成，从而推动更广泛的采用和创新。

主要市场统计
基准年[2023] 82.4亿美元
预测年份 [2024] 88.7亿美元
预测年份 [2030] 141.1亿美元
复合年增长率（%） 7.98%

挑战源于设备和试剂的高成本、技术复杂性以及对熟练人员的需求，这可能会限制获取，特别是在发展中地区。专注于负担得起且用户友好的解决方案的新兴市场参与者正在部分解决这个问题。此外，监管障碍和不同的地区报销框架继续阻碍因素成长。然而，可携式和照护现场PCR 设备的技术创新和改进的多重功能是业务扩展的一个有希望的领域。市场竞争的特点是注重研发和策略合併，以加强产品供应和简化供应链。公司可以利用 PCR 检测中越来越多地采用微射流和奈米技术等趋势来提高通量和准确性。次世代定序仪定序和环境永续技术探索的整合可以提供竞争优势和新的收益来源。产业相关人员可以随时了解监管环境的变化，利用与学术研究机构的合作伙伴关係，开拓克服挑战并利用快速发展的数位和即时PCR技术领域的成长机会。

市场动态：揭示快速发展的数位 PCR 和即时PCR市场的关键市场洞察

供应和需求的动态相互作用正在改变数位 PCR 和即时PCR市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • dPCR和qPCR在临床病毒学诊断的优势
    • 遗传性疾病和感染疾病的增加
    • dPCR和qPCR在植物来源产品认证的应用
  • 市场限制因素
    • dPCR 和 qPCR 技术的严格监管指南
  • 市场机会
    • 液滴数位 PCR (ddPCR) 技术的出现
    • dPCR 和 qPCR 在生物标记发现的应用的出现
  • 市场挑战
    • 与 dPCR 和 qPCR 技术相关的局限性

波特五力：驾驭数位 PCR 和即时PCR市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解数位 PCR 和即时PCR市场的外部影响

外部宏观环境因素在塑造数位 PCR 和即时PCR市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解数位 PCR 和即时PCR市场的竞争格局

对数位 PCR 和即时PCR市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 数位 PCR 和即时PCR市场中的定位矩阵供应商绩效评估

FPNV定位矩阵是评估数位PCR和即时PCR市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製数位 PCR 和即时PCR市场的成功之路

数位 PCR 和即时PCR市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、核准核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • dPCR和qPCR在临床病毒诊断上的优势
      • 遗传性疾病和感染疾病的发生率增加
      • dPCR和qPCR在植物来源产品认证的应用
    • 抑制因素
      • dPCR 和 qPCR 技术的严格监管指南
    • 机会
      • 液滴数位 PCR (ddPCR) 技术的出现
      • dPCR 和 qPCR 在生物标记发现的新应用
    • 任务
      • 与 dPCR 和 qPCR 技术相关的局限性
  • 市场区隔分析
    • 类型：高通量和宽动态范围的首选 qPCR
    • 产品类型：对满足专业最终用户需求的特定应用套件的需求不断增长
    • 应用：在法医学中用于亲子鑑定和犯罪现场调查中低水平 DNA 检测的巨大潜力
    • 最终使用者：dPCR 和 qPCR 在个人化药物开发的关键应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章数位 PCR 和即时PCR市场：按类型

  • dPCR
  • 定量PCR

第七章数位 PCR 和即时PCR市场：依产品类型

  • 装置
  • 试剂/耗材
  • 服务

第 8 章数位 PCR 和即时PCR市场：按应用分类

  • 临床调查
  • 法医学研究所
  • 调查机构

第 9 章 数位 PCR 和即时PCR市场：按最终用户分类

  • 学术研究所
  • 农业与生命科学
  • CRO 和 CDMO
  • 医院和诊断实验室
  • 製药和生物製药公司

第10章美洲数位PCR与即时PCR市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太数位PCR与即时PCR市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的数位PCR和即时PCR市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • QIAGEN 推出 QIAcuity 平台的先进数位 PCR 检测设计工具，提升分子诊断的客製化性和准确性
    • Bio-Rad 推出超灵敏数位 PCR 检测，开创了乳癌先进突变检测和个人化治疗的先河
    • 罗氏推出新一代 qPCR 系统，以改善临床需求并应对分子诊断的公共卫生挑战
    • QIAGEN 推出新的 QIAcuity 数位 PCR套件和更新的软体，以扩大生物製药和食品安全客户的使用范围
    • Seegene 和 Werfen 合作开发综合症qPCR筛检
  • 战略分析和建议

公司名单

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH+Co. KG by Endress+Hauser Group Services AG
  • Azure Biosystems Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocompare by CompareNetworks, Inc.
  • BIOMERIEUX SA
  • Bioneer Corporation
  • Danaher Corporation
  • ELITech Group by Bruker Corp
  • Enzo Life Sciences, Inc.
  • Eppendorf SE
  • Etcon Analytical and Environmental Systems & Services Ltd.
  • Explorea sro
  • F. Hoffmann-La Roche AG
  • Global Engage Sdn. Bhd.
  • Hangzhou Longgene Scientific Instruments Co., Ltd.
  • Heal Force Bio-Meditech Holdings Limited
  • LABGENE Scientific SA
  • Merck KGaA
  • Meridian Bioscience, Inc. by SD Biosensor, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Quidel Corporation
  • R-Biopharm AG
  • RainSure Scientific
  • Roche Diagnostics Corporation
  • Solis BioDyne OU
  • STANDARD BIOTOOLS INC.
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp
Product Code: MRR-8760467AA4C1

The Digital PCR & Real-Time PCR Market was valued at USD 8.24 billion in 2023, expected to reach USD 8.87 billion in 2024, and is projected to grow at a CAGR of 7.98%, to USD 14.11 billion by 2030.

The digital PCR (dPCR) and real-time PCR (qPCR) markets focus on molecular biology techniques used for precise and quantitative amplification of DNA and RNA. Both play crucial roles in diagnostics, research, and applied sciences. The necessity for these technologies is underscored by their applications in detecting genetic disorders, cancer research, pathogen detection (including COVID-19), and genotyping, which expand their scope across diverse end-users such as hospitals, diagnostic centers, and research institutions. The key growth drivers include advancements in biotechnology, a growing prevalence of infectious diseases, increased demand for personalized medicine, and enhanced funding for genomics research. Opportunities lie in enhancements in sensitivity and accuracy, automation, and integration of AI for data interpretation, facilitating broader adoption and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 8.24 billion
Estimated Year [2024] USD 8.87 billion
Forecast Year [2030] USD 14.11 billion
CAGR (%) 7.98%

Challenges stem from the high costs of equipment and reagents, technical complexities, and the need for skilled personnel, which may limit accessibility, especially in developing regions. This is addressed partially by emerging market players focusing on affordable and user-friendly solutions. Furthermore, regulatory hurdles and variability in reimbursement frameworks across regions continue to pose growth impediments. Nevertheless, innovations in portable and point-of-care PCR devices and improvements in multiplexing capabilities are promising areas for business expansion. The market's competitive nature is characterized by a focus on R&D and strategic mergers to bolster product offerings and streamline supply chains. Businesses can leverage trends like the increasing adoption of microfluidics and nanotechnology in PCR assays to enhance throughput and precision. Researching into next-gen sequencing integrations and environmentally sustainable technologies could provide competitive advantages and new revenue streams. It is essential for industry players to stay informed of regulatory changes, leverage collaborations with academic and research bodies, and continue exploring emerging markets to overcome challenges and capitalize on growth opportunities within the rapidly evolving landscape of digital and real-time PCR technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital PCR & Real-Time PCR Market

The Digital PCR & Real-Time PCR Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Benefits of dPCR & qPCR for clinical virology diagnostics
    • Increasing incidences of genetic and infectious diseases
    • Applications of dPCR & qPCR in authenticating plant-derived products
  • Market Restraints
    • Stringent regulatory guidelines regarding dPCR & qPCR techniques
  • Market Opportunities
    • Emergence of droplet digital PCR (ddPCR) technology
    • Emerging applications of dPCR & qPCR in biomarker discovery
  • Market Challenges
    • Limitations associated with dPCR & qPCR techniques

Porter's Five Forces: A Strategic Tool for Navigating the Digital PCR & Real-Time PCR Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital PCR & Real-Time PCR Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital PCR & Real-Time PCR Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital PCR & Real-Time PCR Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital PCR & Real-Time PCR Market

A detailed market share analysis in the Digital PCR & Real-Time PCR Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital PCR & Real-Time PCR Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital PCR & Real-Time PCR Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital PCR & Real-Time PCR Market

A strategic analysis of the Digital PCR & Real-Time PCR Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital PCR & Real-Time PCR Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Inc., Agilent Technologies, Inc., Analytik Jena GmbH+Co. KG by Endress+Hauser Group Services AG, Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocompare by CompareNetworks, Inc., BIOMERIEUX S.A., Bioneer Corporation, Danaher Corporation, ELITech Group by Bruker Corp, Enzo Life Sciences, Inc., Eppendorf SE, Etcon Analytical and Environmental Systems & Services Ltd., Explorea s.r.o, F. Hoffmann-La Roche AG, Global Engage Sdn. Bhd., Hangzhou Longgene Scientific Instruments Co., Ltd., Heal Force Bio-Meditech Holdings Limited, LABGENE Scientific SA, Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor, Inc., Promega Corporation, QIAGEN N.V., Quidel Corporation, R-Biopharm AG, RainSure Scientific, Roche Diagnostics Corporation, Solis BioDyne OU, STANDARD BIOTOOLS INC., Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp.

Market Segmentation & Coverage

This research report categorizes the Digital PCR & Real-Time PCR Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across dPCR and qPCR.
  • Based on Product Type, market is studied across Instruments, Reagents & Consumables, and Services.
  • Based on Application, market is studied across Clinical Research, Forensic Labs, and Research Institutes.
  • Based on End-User, market is studied across Academic & Research Institutes, Agriculture & Lifescience, CROs & CDMOs, Hospitals & Diagnostic Laboratories, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Benefits of dPCR & qPCR for clinical virology diagnostics
      • 5.1.1.2. Increasing incidences of genetic and infectious diseases
      • 5.1.1.3. Applications of dPCR & qPCR in authenticating plant-derived products
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory guidelines regarding dPCR & qPCR techniques
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of droplet digital PCR (ddPCR) technology
      • 5.1.3.2. Emerging applications of dPCR & qPCR in biomarker discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with dPCR & qPCR techniques
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Higher preferences for qPCR for high throughput and a broader dynamic range
    • 5.2.2. Product Type: Growing demand for application-specific kits that address the needs of specialized end-users
    • 5.2.3. Application: Higher potential in forensics for paternity testing and the detection of low-level DNA in crime scene investigations
    • 5.2.4. End-User: Significant applications of dPCR & qPCR in the personalized drug development he
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital PCR & Real-Time PCR Market, by Type

  • 6.1. Introduction
  • 6.2. dPCR
  • 6.3. qPCR

7. Digital PCR & Real-Time PCR Market, by Product Type

  • 7.1. Introduction
  • 7.2. Instruments
  • 7.3. Reagents & Consumables
  • 7.4. Services

8. Digital PCR & Real-Time PCR Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Research
  • 8.3. Forensic Labs
  • 8.4. Research Institutes

9. Digital PCR & Real-Time PCR Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Agriculture & Lifescience
  • 9.4. CROs & CDMOs
  • 9.5. Hospitals & Diagnostic Laboratories
  • 9.6. Pharmaceutical & Biopharmaceutical Companies

10. Americas Digital PCR & Real-Time PCR Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Digital PCR & Real-Time PCR Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Digital PCR & Real-Time PCR Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. QIAGEN Introduces Advanced Digital PCR Assay Design Tool for QIAcuity Platform, Boosting Customization and Precision in Molecular Diagnostics
    • 13.3.2. Bio-Rad Unveils Ultrasensitive Digital PCR Assay, Pioneering Advanced Breast Cancer Mutation Detection and Personalized Treatment
    • 13.3.3. Roche Launches Next-Generation qPCR System to Advance Clinical Needs in Molecular Diagnostics and Address Public Health Challenges
    • 13.3.4. QIAGEN Launches New QIAcuity Digital PCR Kits and Updated Software to Expand Use by Biopharma and Food Safety Customers
    • 13.3.5. Seegene and Werfen Partner on Syndromic qPCR Assays Development
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Analytik Jena GmbH+Co. KG by Endress+Hauser Group Services AG
  • 4. Azure Biosystems Inc.
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Biocompare by CompareNetworks, Inc.
  • 8. BIOMERIEUX S.A.
  • 9. Bioneer Corporation
  • 10. Danaher Corporation
  • 11. ELITech Group by Bruker Corp
  • 12. Enzo Life Sciences, Inc.
  • 13. Eppendorf SE
  • 14. Etcon Analytical and Environmental Systems & Services Ltd.
  • 15. Explorea s.r.o
  • 16. F. Hoffmann-La Roche AG
  • 17. Global Engage Sdn. Bhd.
  • 18. Hangzhou Longgene Scientific Instruments Co., Ltd.
  • 19. Heal Force Bio-Meditech Holdings Limited
  • 20. LABGENE Scientific SA
  • 21. Merck KGaA
  • 22. Meridian Bioscience, Inc. by SD Biosensor, Inc.
  • 23. Promega Corporation
  • 24. QIAGEN N.V.
  • 25. Quidel Corporation
  • 26. R-Biopharm AG
  • 27. RainSure Scientific
  • 28. Roche Diagnostics Corporation
  • 29. Solis BioDyne OU
  • 30. STANDARD BIOTOOLS INC.
  • 31. Takara Bio USA, Inc.
  • 32. Thermo Fisher Scientific Inc.
  • 33. Zymo Research Corp

LIST OF FIGURES

  • FIGURE 1. DIGITAL PCR & REAL-TIME PCR MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIGITAL PCR & REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIGITAL PCR & REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL PCR & REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL PCR & REAL-TIME PCR MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DPCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY AGRICULTURE & LIFESCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CROS & CDMOS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. DIGITAL PCR & REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. DIGITAL PCR & REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2023